Kuban's biotechnology gains Kondratyev's progress report

Oct 5

Kondratyev welcomes the forum and argues that regional adoption of innovation must improve daily life. He describes expanded access to high-technology medical care, settling after several verbal corrections on 50,000 people, and more than 90 primary-care facilities. He says medical/pharmaceutical shipments have grown almost threefold since 2020, while also giving approximately 1.5 billion then and 7.5 billion in the previous year; the recording does not reconcile those figures. He cites maltodextrin production established about three years earlier and silicon dioxide production from rice husks as examples of domestic biotechnology replacing imports and using waste. The plants' names and precise commissioning dates are not supplied.

Kondratyev reports expanded high-technology and primary medical access, medical/pharmaceutical production growth and regional biotechnology examples at BIOPROM on October 5. After correcting himself he gives 50,000 people for high-technology care and cites more than ninety primary-care facilities. He describes maltodextrin and rice-husk silicon dioxide production. His nearly-threefold growth characterization and approximately 1.5-to-7.5-billion shipment figures are preserved without reconciliation. Plant identities and commissioning dates are unstated.